Login / Signup

Thromboembolic and hemorrhagic risks after vaccination against SARS-CoV-2: a systematic review and meta-analysis of randomized controlled trials.

Noppacharn UaprasertKrissana PanrongPonlapat RojnuckarinThita Chiasakul
Published in: Thrombosis journal (2021)
Vaccines against SARS-CoV-2 are not associated with an increased risk of thromboembolism, hemorrhage, and thromboembolism/hemorrhage-related death.
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • atrial fibrillation
  • human health
  • coronavirus disease